Study Uncovers Mechanism Of Drug Resistance In Form Of Lung Cancer
BOSTON -- Dana-Farber Cancer Institute researchers and their colleagues have demonstrated that a genetic error so scarce it can't be detected with some standard screening equipment is often responsible for the loss of effectiveness of front-line drugs against non-small cell lung cancer.